Abstract
Analytical true positive workplace drug testing results due to use of prescription medication or OTC (over-the-counter) medication do occur. Amphetamine positive result due to prescription medication was discussed in Chap. 9. Prescription use of any benzodiazepine may cause positive test results although benzodiazepine is not one of the SAMHSA drugs. Topical use of cocaine may cause positive results in workplace drug testing. Many pain medications contain opiates and use of such medication leads to false positive opiate tests. Marinol is synthetic marijuana which is metabolized in the same way as marijuana and can cause positive marijuana results in workplace drug testing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007; 10: 399–424.
Manchikanti L, Singh A. Therapeutic opioids: a ten year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11(2 Suppl): S63–S88.
Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict 2009; 18: 5–14.
DeRienz RT, Holler JM, Manos ME, Jemionek J et al. Evaluation of four immunoassays screening kits for the detection of benzodiazepines in urine. J Anal Toxicol 2008; 32: 433–437.
Klette KL, Wiegand RF, Horn CK, Stout PR et al. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry. J Anal Toxicol 2005; 19: 193–200.
Fraser AD, Jowell P. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine. J Anal Toxicol 1998; 22: 50–54.
Piergies AA, Sainati S, Roth-Schechter B. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens. Arch Pathol Lab med 1997; 121: 392–394.
ElSohly MA, Gul W, Murphy TP, Avula B. LC-(TOF) MS analysis of benzodiazepines in urine from alleged victims of drug facilitated sexual assault. J Anal Toxicol 2007; 31: 505–514.
ElSohly MA, Gul W, Avula B, Murphy TP et al. Simultaneous analysis of thirty five benzodiazepines using liquid chromatography-mass spectrometry time of flight. J Anal Toxicol 2008; 32: 547–561.
Reisfield GM, Haddad J, Wilson GR, Johannsen LM et al. Failure of amoxicillin to produce false-positive urine screens for cocaine metabolite. J Anal Toxicol 2008; 32: 315–318.
Bruns AD, Zeiske LA, Jacobs AJ. Analysis of the cocaine metabolite in the urine of patients and physicians during clinical use. Otolaryngol Head Neck Surg 1994; 111: 722–726.
Kavanagh KT, Maijub AG, Brown JR. Passive exposure to cocaine in medical personnel and its effect on urine drug screening test. Otolaryngol Head Neck Surg 1992; 107: 363–366.
Jacobson DM, Berg R, Grinstead GF, Kruse JR. Duration of positive urine for cocaine metabolite after ophthalmic administration: implications for testing patients with suspected Horner syndrome using ophthalmic cocaine. Am J Ophthalmol 2001; 131: 742–747.
Patrinely JR, Cruz OA, Reyna GS, King JW. The use of cocaine as an anesthetic in lacrimal surgery. J Anal Toxicol 1994; 18: 54–56.
Altieri M, Bogema S, Schwartz RH. TAC topical anesthesia produces positive urine test for cocaine. Ann Emerg Med 1990; 19: 577–579.
Smith ML, Hughes RO, Levine B, Dickerson S et al. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. J Anal Toxicol 1995; 19: 18–26.
Dunn KE, Sigmon SC, McGee MR, Heil MR et al. Evaluation of ongoing oxycodone abuse among methadone maintained patients. J Subst Abuse Test 2008; 35: 451–456.
Popa C, Beck O, Brodin K. Morphine formation from ethylmorphine: implications for drugs of abuse testing in urine. J Anal Toxicol 1998; 22: 142–147.
Wasam AD, Michna E, Janfaza D, Greenfield S et al. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine. Pain Med 2008; 9: 918–923.
Cone EJ, Caplan YH, Moser F, Robert T et al. Evidence that morphine is metabolized to hydromorphone but not to oxymorphone. J Anal Toxicol 2008; 32(4): 319–323.
Oyler JM, Cone EJ, Joseph RE Jr, Huestis MA. Identification of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol 2000; 24: 530–535.
Murao S, Manabe H, Yamashita T, Sekikawa T. Intoxication with over the counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis. Intern Med 2008; 47: 1013–1015.
Coffman KL. The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects. Curr Opin Organ Transplant 2008; 13: 189–195.
Rossi S, Yash T, Bentley H, van der Brande G et al. Characterization of interference with six commercial d9-tetrahydrocannabinol immunoassays by efavirenz glucuronide in urine. Clin Chem 2006; 52: 896–897 [letter to the Editor].
ElSohly MA, deWit H, Wachtel SR, Feng S et al. Delta 9-tetrahydrocannabivarin as a marker for ingestion of marijuana versus Marinol: results of a clinical study. J Anal Toxicol 2001; 25: 565–571.
di Tomaso E, Beltramo M, Piomelli D. Brain cannabinoids in chocolate. Nature 1996; 382(6593): 677–678.
James JS. Marijuana and chocolate. AIDS Treat News 1996; 18(2567): 3–4.
Tytgat J, Van Boven M, Daenens P. Cannabinoid mimics in chocolate utilized as an argument in court. Int J Legal Med 2000; 113: 137–139.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Dasgupta, A. (2010). Analytical True Positives in Workplace Drugs Testings Due to Use of Prescription and OTC Medications. In: Beating Drug Tests and Defending Positive Results. Humana Press. https://doi.org/10.1007/978-1-60761-527-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-527-9_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-526-2
Online ISBN: 978-1-60761-527-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)